Hikma Triumphs As Vascepa Induced-Infringement Case Dismissed
Amarin Had Pursued Firm Over Skinny-Label Generic Icosapent Ethyl Capsules
An attack on Hikma’s skinny-label generic version of Vascepa by originator Amarin, claiming induced infringement of patents protecting a cardiovascular indication, has been dismissed in the US.
